Orthofix Medical Inc (OFIX) Stock Forecast & Price Target
Orthofix Medical Inc · NASDAQ
$9.29-0.02 (-0.21%)
15-min delayed · Sep 4, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Orthofix Medical Inc, 3 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $13.00 to $17.00, so the covering firms are broadly aligned. The average target of $14.75 sits 59% above the current $9.29. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.35 next quarter toward $0.37 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy375%
Hold125%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Orthofix Medical Inc.
As of Sep, 3 of 4 firms rate OFIX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
OFIX EPS & revenue forecast
EPS · NEXT QUARTER
$0.35
Range $0.35 – $0.35 · 1 analysts · +47% YoY
Next period, 1 analysts expect Orthofix Medical Inc to earn $0.35 a share (range $0.35 – $0.35), versus $0.24 a year earlier. Full-year consensus is $0.41, growing to $0.37 the year after.
REVENUE · NEXT QUARTER
$232.7M
Range $231.0M – $234.0M · 1 analysts · +6% YoY
Revenue is expected to reach $232.7M (range $231.0M – $234.0M), +5.8% year-over-year. Full-year consensus is $851.0M, rising to $871.9M next year.
Top analysts covering Orthofix Medical Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OFIX.
#1
JW
Jason Wittes
Roth MKM · Rank #311
Buy
$22.00+136.8% to target
Overall win rate
39%
+ Follow
#2
David Turkaly
JMP Securities · Rank #346
Hold
No targeton OFIX
Overall win rate
33%
+ Follow
#3
Michael Petusky
Barrington Research · Rank #373
Buy
$17.00+83.0% to target
Overall win rate
31%
+ Follow
#4
CB
Caitlin Burrows
Canaccord Genuity
Buy
$13.00+39.9% to target
Coverage
—
+ Follow
#5
TS
Thomas Stephan
Stifel
Buy
$15.00+61.5% to target
Coverage
—
+ Follow
OFIX stock forecast FAQ
What is OFIX's average 12-month price target?+
The 4 analysts with a live target average $14.75 for Orthofix Medical Inc over the next 12 months, ranging from a $17.00 high to a $13.00 low.
Is OFIX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 3 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for OFIX?+
The Street-high target is $17.00 (Barrington Research), and the Street-low is $13.00 (Canaccord Genuity). The average of all 4 active targets is $14.75.
How many Wall Street analysts cover OFIX?+
4 analysts have an active rating on Orthofix Medical Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering OFIX?+
Among analysts who currently cover OFIX, Jason Wittes of Roth MKM has the strongest overall Quantellect track record (Rank #311). Their current call is Buy with a $22.00 target.
What is Orthofix Medical Inc's projected EPS for next quarter?+
The consensus estimate is $0.35 per share (range $0.35 – $0.35) across 1 analysts. Full-year EPS is projected at $0.41, rising to $0.37 the following year.
How much revenue is Orthofix Medical Inc expected to report next quarter?+
Consensus revenue is $232.7M (range $231.0M – $234.0M). Full-year revenue is projected at $851.0M, growing to $871.9M next year.
Have analysts been upgrading or downgrading OFIX lately?+
As of Sep, 3 of 4 firms rate OFIX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OFIX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
